Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study.
Miller KE, Cassady KA, Roth JC, Clements J, Schieffer KM, Leraas K, Miller AR, Prasad N, Leavenworth JW, Aban IB, Whitley RJ, Gillespie GY, Mardis ER, Markert JM.
Miller KE, et al. Among authors: roth jc.
Clin Cancer Res. 2022 Feb 1;28(3):498-506. doi: 10.1158/1078-0432.CCR-21-2636.
Clin Cancer Res. 2022.
PMID: 35105718
Free PMC article.